Global Med Technologies(R) Licenses Laboratory Solution to Historic European Hospital
December 17 2009 - 9:00AM
PR Newswire (US)
1,000-Bed French Hospital Chooses Inlog's EdgeLab Software DENVER,
Dec. 17 /PRNewswire-FirstCall/ -- Global Med Technologies®, Inc.
("Global Med" or the "Company") (OTC:GLOB) (BULLETIN BOARD: GLOB) ,
an international healthcare information technology company, today
announced that its Inlog, SA subsidiary has licensed its
EdgeLab(TM) Laboratory Information Management Software (Marketed as
"Labo Serveur" in France) to the centuries-old Centre Hospitalier
de Verdun in Verdun, France. Terms of the agreement were not
disclosed. (Logo:
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO) EdgeLab
is a leading laboratory information management system in Europe
used by more than 150 licensed laboratories. EdgeLab can be
interfaced to more than 1,000 analyzers and interchanges data with
all major hospital healthcare software applications. Its
comprehensive range of laboratory functionality can be easily
configured to meet the business needs of large, diverse, multi-site
hospital laboratories, as well as small, single-site hospitals. The
Verdun Hospital Laboratory will use EdgeLab to process over 350
patient files per day. The system will be interfaced to six
analyzers and one instrument middleware product. Will Willman,
Global Med's Sr. Vice President of Sales and Marketing EU/ME/Asia,
stated, "We are very pleased that the historic Centre Hospitalier
de Verdun has selected Inlog's EdgeLab solution to upgrade their
laboratory software. Verdun's decision was a result of the
excellent references that our software received from the Inlog
customers that Verdun contacted, the full range of features the
software offers, the integrated SapaNet (El Dorado Control) quality
management software, and the ability to interface to our EdgeTrack
transfusion management software (not for sale in the U.S.) on the
same database." About Centre Hospitalier de Verdun The Verdun
Hospitals have a rare and fascinating history. Founded in the 7th
century, the first written evidence of a care facility near the
current location was in 1093. The hospital has evolved through the
centuries: the thirteenth century saw a name change to
Sainte-Catherine; in 1570 a general hospital was formed; during the
French Revolution the organization Hospices Civils de Verdun
(Sainte-Catherine and Saint-Nicolas) was created; Sainte-Catherine
was partially destroyed during WWI, and then repaired; St. Nicolas
was used as a military hospital during WWII. Between World War II
and 2007, Verdun hospitals expanded to four separate facilities
including Desandrouins and Saint Joseph. At almost 1,000 beds in
three different sites, Verdun handles about 25,000 emergencies per
year. Nearly 1,800 people work at the hospital including more than
170 physicians. About Global Med Technologies®, Inc. Global Med
Technologies, Inc. is an international healthcare information
technology company which develops regulated and non-regulated
products and services for the healthcare industry. As a leading
provider of blood and laboratory systems and services, Global Med's
products are deployed in 20 countries and serve over 2,100
transfusion centers, blood banks and laboratory sites. Global Med's
domestic companies are Wyndgate Technologies®, a leader in software
products and services for donor centers and hospital transfusion
services; eDonor®, which offers web-based donor relationship
management systems; Hemo-Net®, a healthcare application service
provider; and PeopleMed®, Inc., which implements cost-effective
software validation, consulting and compliance solutions to
hospitals and donor centers. Global Med's European subsidiary,
Inlog, SA, is a leading developer of donor center and transfusion
management systems as well as cellular therapy software, laboratory
information systems and quality assurance medical software systems
internationally. For more information about Global Med's products
and services, please call 800-996-3428 or visit
http://www.globalmedtech.com/. This news release may include
statements that constitute forward-looking statements, usually
containing the words "believe," "estimate," "project," "expects" or
similar expressions. These statements are made pursuant to the safe
harbor provisions of the Private Securities Litigation Reform Act
of 1995. Forward-looking statements inherently involve risks and
uncertainties that could cause actual results to differ materially
from the forward-looking statements. By making these
forward-looking statements, the Company undertakes no obligation to
update these statements for revisions or changes after the date of
this news release.
http://www.newscom.com/cgi-bin/prnh/20040226/GLOBALMEDLOGO
http://photoarchive.ap.org/ DATASOURCE: Global Med Technologies,
Inc. CONTACT: Michael I. Ruxin, M.D. of Global Med Technologies,
Inc., +1-303-238-2000 Web Site: http://www.globalmedtech.com/
Copyright